Safety Study of Vx006 Vaccine in Solid Tumor Patients

计划入组 23 人 · 首次发布于 2014 年 11 月 13 日

Redirected High Affinity Gag-Specific Autologous T Cells for HIV Gene Therapy

计划入组 2 人 · 首次发布于 2009 年 10 月 7 日

Gene-Modified Immune Cells (FH-MCVA2TCR) in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer

计划入组 7 人 · 首次发布于 2018 年 11 月 20 日

HLA-A02 restricted HIG2

TRuC Treg cells targeting HLA-A02(TCR2 Therapeutics)

anti-HLA-A02 TRuC Treg-cell therapy (TCR2 Therapeutics)

AN2 Therapeutics

United States

HLT, Inc.

United States

LABORATOIRE HRA PHARMA

Spain

Greenwich LifeSciences' GLSI-100 Receives FDA Fast Track Designation for HER2-Positive Breast Cancer

Novel Treatment Landscape Expands for Uveal Melanoma with Multiple Promising Therapies in Development

CDR-Life's Novel T Cell Engagers Show Superior Potency Against Solid Tumors in Preclinical Studies